Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Epigenetic changes in patients with multiple sclerosis.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Co-enzyme Q10 and idebenone use in Friedreich's ataxia.
Helminth therapy and multiple sclerosis.
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Rehabilitation interventions in multiple sclerosis: an overview.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level.
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Receptos Reports Positive Phase 2 Results for RPC1063 in Relapsing Multiple Sclerosis
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Pages